FI20020642A0 - Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina - Google Patents

Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina

Info

Publication number
FI20020642A0
FI20020642A0 FI20020642A FI20020642A FI20020642A0 FI 20020642 A0 FI20020642 A0 FI 20020642A0 FI 20020642 A FI20020642 A FI 20020642A FI 20020642 A FI20020642 A FI 20020642A FI 20020642 A0 FI20020642 A0 FI 20020642A0
Authority
FI
Finland
Prior art keywords
polycyclic compounds
adrenoceptor antagonists
alpha2
potent
potent alpha2
Prior art date
Application number
FI20020642A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Belle David Din
Reija Jokela
Arto Tolvanen
Antti Haapalinna
Arto Karjalainen
Jukka Sallinen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20020642A priority Critical patent/FI20020642A0/fi
Publication of FI20020642A0 publication Critical patent/FI20020642A0/fi
Priority to UA20041108959A priority patent/UA80968C2/uk
Priority to NZ535950A priority patent/NZ535950A/en
Priority to EP03712185A priority patent/EP1490361B1/en
Priority to PCT/FI2003/000255 priority patent/WO2003082866A1/en
Priority to DE60316672T priority patent/DE60316672T2/de
Priority to KR10-2004-7015702A priority patent/KR20040111473A/ko
Priority to AU2003216760A priority patent/AU2003216760A1/en
Priority to MXPA04009601A priority patent/MXPA04009601A/es
Priority to YU87204A priority patent/RS87204A/sr
Priority to AT03712185T priority patent/ATE374773T1/de
Priority to TW092107597A priority patent/TW200400028A/zh
Priority to CA002480695A priority patent/CA2480695A1/en
Priority to EA200401301A priority patent/EA008537B1/ru
Priority to JP2003580331A priority patent/JP2005522468A/ja
Priority to HU0500201A priority patent/HUP0500201A2/hu
Priority to BR0309028-0A priority patent/BR0309028A/pt
Priority to PL03372657A priority patent/PL372657A1/xx
Priority to US10/510,019 priority patent/US7592350B2/en
Priority to CNB038084716A priority patent/CN100372845C/zh
Priority to IL16420303A priority patent/IL164203A0/xx
Priority to ZA200407913A priority patent/ZA200407913B/xx
Priority to IS7482A priority patent/IS7482A/is
Priority to NO20044627A priority patent/NO20044627L/no
Priority to HR20041026A priority patent/HRP20041026A2/xx
Priority to HK05107766A priority patent/HK1075660A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20020642A 2002-04-03 2002-04-03 Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina FI20020642A0 (fi)

Priority Applications (26)

Application Number Priority Date Filing Date Title
FI20020642A FI20020642A0 (fi) 2002-04-03 2002-04-03 Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina
UA20041108959A UA80968C2 (en) 2002-04-03 2003-03-04 Polycyclic compounds as potent alpha-2 adrenoceptor antagonists
IL16420303A IL164203A0 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpah2-adrenoceptorantagonists
CA002480695A CA2480695A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
EA200401301A EA008537B1 (ru) 2002-04-03 2003-04-03 Полициклические соединения как эффективные антагонисты альфа2-адренорецептора
PCT/FI2003/000255 WO2003082866A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
DE60316672T DE60316672T2 (de) 2002-04-03 2003-04-03 Polycyclische verbindungen als potente alpha2-adrenoceptor antagonisten
KR10-2004-7015702A KR20040111473A (ko) 2002-04-03 2003-04-03 강력한 알파 2-아드레노셉터 길항제인 폴리사이클릭 화합물
AU2003216760A AU2003216760A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
MXPA04009601A MXPA04009601A (es) 2002-04-03 2003-04-03 Compuestos policiclicos como potentes antagonistas del adreno-receptor alfa-2.
YU87204A RS87204A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
AT03712185T ATE374773T1 (de) 2002-04-03 2003-04-03 Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
TW092107597A TW200400028A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
NZ535950A NZ535950A (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
EP03712185A EP1490361B1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
JP2003580331A JP2005522468A (ja) 2002-04-03 2003-04-03 強力なα２−アドレナリン作用性レセプターの拮抗薬としての多環式化合物
HU0500201A HUP0500201A2 (hu) 2002-04-03 2003-04-03 Policiklusos vegyületek, mint potenciális alfa2-adrenoceptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
BR0309028-0A BR0309028A (pt) 2002-04-03 2003-04-03 Compostos policìclicos como antagonistas potentes de alfa2-adrenoceptores
PL03372657A PL372657A1 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
US10/510,019 US7592350B2 (en) 2002-04-03 2003-04-03 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
CNB038084716A CN100372845C (zh) 2002-04-03 2003-04-03 作为有效的α2－肾上腺素受体拮抗剂的多环化合物
ZA200407913A ZA200407913B (en) 2002-04-03 2004-09-30 Polycyclic compounds as potent alpha2-adrenoceptorantagonists.
IS7482A IS7482A (is) 2002-04-03 2004-10-01 Fjölhringa efnasambönd sem sterk alfa2-adrenóviðtakamótlyf
NO20044627A NO20044627L (no) 2002-04-03 2004-10-27 Polysykliske forbindelser som sterke alfa2-adrenoseptorantagonister
HR20041026A HRP20041026A2 (en) 2002-04-03 2004-11-02 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
HK05107766A HK1075660A1 (en) 2002-04-03 2005-09-05 Polycyclic compounds as potent alpha2-adrenoceptorantagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20020642A FI20020642A0 (fi) 2002-04-03 2002-04-03 Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina

Publications (1)

Publication Number Publication Date
FI20020642A0 true FI20020642A0 (fi) 2002-04-03

Family

ID=8563695

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020642A FI20020642A0 (fi) 2002-04-03 2002-04-03 Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina

Country Status (6)

Country Link
KR (1) KR20040111473A (uk)
FI (1) FI20020642A0 (uk)
NO (1) NO20044627L (uk)
TW (1) TW200400028A (uk)
UA (1) UA80968C2 (uk)
ZA (1) ZA200407913B (uk)

Also Published As

Publication number Publication date
NO20044627L (no) 2004-10-27
UA80968C2 (en) 2007-11-26
TW200400028A (en) 2004-01-01
KR20040111473A (ko) 2004-12-31
ZA200407913B (en) 2005-10-06

Similar Documents

Publication Publication Date Title
DK1562595T3 (da) Diarylethere som opioidreceptorantagonister
IS8501A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
SE0301569D0 (sv) Novel compounds
DE60335915D1 (de) Myostatin hemmende bindungsstoffe
IS8108A (is) Ný efnasambönd
ATE368042T1 (de) Cephemverbindungen
IS8228A (is) Ný asetídínefnasambönd
IS7381A (is) Efnasambönd
IS8089A (is) Efnasambönd
IS7414A (is) Oxó-azabísýklísk efnasambönd
IS8292A (is) Ný efnasambönd
DE602004004278D1 (de) 4-cycloalkylaminopyrazolopyrimidin als nmda/nr2b-antagonisten
DK1648882T3 (da) 3-fluor-piperidiner som NMDA/NR2B-antagonister
NO20045659L (no) Forbindelser
IS8278A (is) Sýkóprópýl afleiður sem NK3 viðtaka mótlyf
DE60210058D1 (de) Alkoxycarbonylamino-heteroaryl-carbonsäurederivate als ip-antagonisten
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
DK1261588T3 (da) Imidazolforbindelser som alfa2-adrenoceptorantagonister
FI20020642A0 (fi) Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina
NO20031736D0 (no) Forbindelser
SE0303452D0 (sv) New compounds
FI20020643A0 (fi) Polysykliset yhdisteet tehokkaina alfa2-adrenoseptoriantagonisteina
SE0203348D0 (sv) Novel compounds
SE0203722D0 (sv) Tetracyclic Immunomodulatory Compounds
SE0200118D0 (sv) Novel compounds